Aramex, a global leader in logistics and transportation, has been awarded the Good Distribution Practice (GDP) certification for Quality and Freight in the UAE, further solidifying its reputation as a trusted partner in the region’s healthcare supply chain.
This certification highlights Aramex’s commitment to maintaining the highest standards in the distribution and handling of pharmaceutical products, ensuring their quality, safety, and integrity throughout the supply chain.
The GDP certification is a prestigious recognition within the healthcare industry, representing a set of rigorous standards and guidelines that guarantee the safe and efficient distribution of pharmaceutical products. This achievement underscores the capabilities of Aramex’s Healthcare division in managing the complexities of the pharmaceutical supply chain, where the quality of products directly impacts patient well-being and safety.
Suzandi Viljoen, Global Segment Manager for Aramex Healthcare, expressed pride in the accomplishment: “We are delighted to receive GDP certification for Quality and Freight, which reflects our relentless dedication to maintaining the highest standards in healthcare logistics. At Aramex, we are proud of the work we do to support the pharmaceutical needs of the UAE and beyond and improve people’s health. We will continue to invest in improving the quality and efficiency of our services and take great care in ensuring the safety of all products being transported with our services, thereby contributing to the region’s journey to become a global healthcare hub.”
Aramex’s Healthcare division offers a range of innovative solutions tailored to the pharmaceutical industry, including validated packaging solutions for temperature-sensitive products, dynamic tracking, and real-time shipment visibility. These services ensure that healthcare products, including those used in clinical trials, are transported safely and efficiently, with direct-to-patient deliveries providing customizable, quick, and reliable supply chain options.
Othman Aljeda, CEO of Aramex, emphasized the significance of this certification: “Receiving the latest Good Distribution Practices (GDP) certification is a proud moment for Aramex as our healthcare supply chain business continues to scale new heights. As a global benchmark of quality assurance in the pharmaceutical sector, this certification is not only a testament to Aramex’s capability in world-class handling and distribution of such consignments, but also reflects the quality of our human capital and their technical proficiency at every step of this sensitive process. This achievement wouldn’t have been possible without their dedication and hard work, and we are committed to delivering a lot more of such state-of-the-art solutions for esteemed clients across our strategic verticals in the months and years ahead.”
The GDP certification aligns with Aramex’s strategic expansion into the healthcare sector, underscoring the company’s commitment to diversifying its business and meeting the evolving needs of its customers in this vital industry. As part of this strategy, Aramex is developing several GDP-compliant sites and introducing a fleet of temperature-controlled vehicles to ensure the integrity and safety of pharmaceutical products throughout the supply chain.
This milestone marks a significant step forward for Aramex in its mission to become a leading provider of healthcare logistics in the region, supporting the UAE’s vision to establish itself as a global healthcare hub.
